LILRB2

LILRB2

LILRB2 분자 정보

Molecule Name
Leukocyte immunoglobulin-like receptor subfamily B member 2
분자 별명
LILRB2,ILT4,LIR2,MIR10,CD85d
Drug Development Progress
임상 약물 수11
시판 약물 수0
최고 연구 개발 단계Phase 2 Clinical
표적 별명
Leukocyte immunoglobulin-like receptor 2,CD85 antigen-like family member D,Immunoglobulin-like transcript 4,ILT-4,Monocyte/macrophage immunoglobulin-like receptor 10,MIR-10,CD_antigen: CD85d,LILRB2,Leukocyte Immunoglobulin Like Receptor B2,Leucocyte Ig-Like Receptor B2,MIR10,Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 2,Ig-Like Transcript 4,Myeloid Inhibitory Receptor 10,CD85d Antigen,ILT4,LIR2,CD85d,LIR-2,LIRB2
분자 배경
Leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2) is also known as CD85 antigen-like family member D (CD85d), Immunoglobulin-like transcript 4 (ILT-4), Monocyte / macrophage immunoglobulin-like receptor 10 (MIR-10), which is a member of the the subfamily B class of LIR receptors. LILRB2 is receptor for class I MHC antigens. LILRB2 recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. LILRB2 competes with CD8A for binding to class I MHC antigens. LILRB2 / CD85d inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions.

LILRB2 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

항체 프로젝트 거래 플랫폼

프로젝트 이름프로젝트 단계분자 유형분자 출처질병 영역적응증
LILRB2 mAb - 01PCCMonoclonalHumanized MouseSolid TumorSolid tumor
프로젝트 이름
LILRB2 mAb - 01
프로젝트 단계
PCC
분자 유형
Monoclonal
분자 출처
Humanized Mouse
질병 영역
Solid Tumor
적응증
Solid tumor